Published in Am J Vet Res on May 01, 1996
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev (2003) 2.03
Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle. J Bacteriol (2009) 1.76
Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol (2009) 1.71
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect Immun (1999) 1.62
Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin Diagn Lab Immunol (1999) 1.54
Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis. Infect Immun (2003) 1.41
Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One (2008) 1.37
Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun (2004) 1.33
Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun (2000) 1.32
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun (1998) 1.29
Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb Cell Fact (2006) 1.22
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun (2000) 1.22
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun (2000) 1.18
What have we learned from brucellosis in the mouse model? Vet Res (2012) 1.13
Brucellosis: the case for live, attenuated vaccines. Vaccine (2009) 1.12
Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect Immun (2000) 1.11
Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain. Infect Immun (2011) 1.10
Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. BMC Immunol (2011) 1.08
Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect Immun (2001) 1.06
Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. Infect Immun (2004) 1.03
O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry. Clin Diagn Lab Immunol (1998) 0.98
Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics. Front Cell Infect Microbiol (2012) 0.97
Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51. Clin Diagn Lab Immunol (2005) 0.96
Protective properties of rifampin-resistant rough mutants of Brucella melitensis. Infect Immun (2005) 0.94
Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect Immun (2006) 0.91
Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice. Clin Dev Immunol (2011) 0.90
Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice. J Bacteriol (2005) 0.87
Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice. Infect Immun (2011) 0.84
In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp. Clin Vaccine Immunol (2012) 0.82
Brucella abortus invasion of synoviocytes inhibits apoptosis and induces bone resorption through RANKL expression. Infect Immun (2013) 0.82
Mechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival. Infect Immun (2014) 0.81
Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18. PLoS One (2011) 0.79
Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis. Infect Immun (2003) 0.77
Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19. Jundishapur J Microbiol (2015) 0.75
Overexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide. Front Cell Infect Microbiol (2015) 0.75
Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene (1995) 18.98
pBBR1MCS: a broad-host-range cloning vector. Biotechniques (1994) 8.71
Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol (1991) 4.67
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40
PATRIC: the VBI PathoSystems Resource Integration Center. Nucleic Acids Res (2006) 3.06
Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol (1989) 2.73
Wild boars as sources for infectious diseases in livestock and humans. Philos Trans R Soc Lond B Biol Sci (2009) 1.99
Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun (1994) 1.93
Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides. Infect Immun (1979) 1.93
A versatile computational pipeline for bacterial genome annotation improvement and comparative analysis, with Brucella as a use case. Nucleic Acids Res (2007) 1.68
Brucella abortus in captive bison. I. Serology, bacteriology, pathogenesis, and transmission to cattle. J Wildl Dis (1990) 1.64
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect Immun (1999) 1.62
Cloning of the Escherichia coli genes for the biosynthetic enzymes for polyamines. Methods Enzymol (1983) 1.60
Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin Diagn Lab Immunol (1999) 1.54
Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex. Am J Vet Res (1984) 1.54
Antibody response to antigens distinct from smooth lipopolysaccharide complex in Brucella infection. Infect Immun (1978) 1.52
Influence of supplemental selenium on humoral immune responses in weaned beef calves. Am J Vet Res (1989) 1.51
Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun (1994) 1.47
Bovine veneral vibriosis: antigenic variation of the bacterium during infection. Infect Immun (1975) 1.46
Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice. Microb Pathog (1992) 1.45
Characterization of monoclonal antibodies directed against swine leukocytes. Vet Immunol Immunopathol (1986) 1.42
Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus. Vet Immunol Immunopathol (1990) 1.41
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun (1994) 1.35
Nucleotide sequence and analysis of the speA gene encoding biosynthetic arginine decarboxylase in Escherichia coli. J Bacteriol (1990) 1.34
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun (2001) 1.33
Analysis and sequence of the speB gene encoding agmatine ureohydrolase, a putrescine biosynthetic enzyme in Escherichia coli. J Bacteriol (1990) 1.32
Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun (2000) 1.32
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun (1998) 1.29
Bovine venereal vibriosis: variations in immunoglobulin class of antibodies in genital secretions and serum. Infect Immun (1974) 1.28
The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice. Infect Immun (1999) 1.24
Bovine veneral vibriosis: cure of genital infection in females by systemic immunization. Infect Immun (1975) 1.24
Cytological and deoxyribonucleic acid-deoxyribonucleic acid hybridization studies on lactobacillus isolates from San Francisco sourdough. Appl Microbiol (1973) 1.23
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun (2000) 1.22
Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun (1999) 1.21
Superoxide dismutases of virulent and avirulent strains of Brucella abortus. Vet Microbiol (1991) 1.20
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun (2000) 1.18
Electroporation of a suicide plasmid bearing a transposon into Brucella abortus. Microb Pathog (1990) 1.17
Negative control of ornithine decarboxylase and arginine decarboxylase by adenosine-3':5'-cyclic monophosphate in Escherichia coli. Mol Gen Genet (1982) 1.16
Rapid identification of smooth Brucella species with a monoclonal antibody. J Clin Microbiol (1987) 1.15
Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse. Res Vet Sci (1992) 1.15
Coronavirus and Pasteurella infections in bovine shipping fever pneumonia and Evans' criteria for causation. J Clin Microbiol (2000) 1.14
In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J (1988) 1.12
Molecular cloning and nucleotide sequence analysis of the gene encoding the immunoreactive Brucella abortus Hsp60 protein, BA60K. Microb Pathog (1992) 1.12
Antagonistic transcriptional regulation of the putrescine biosynthetic enzyme agmatine ureohydrolase by cyclic AMP and agmatine in Escherichia coli. J Bacteriol (1984) 1.12
Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol Biol (1995) 1.11
A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods (1997) 1.11
Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine (2001) 1.11
Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res (1998) 1.10
Biosynthetic arginine decarboxylase in Escherichia coli is synthesized as a precursor and located in the cell envelope. J Bacteriol (1985) 1.08
Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant. Res Vet Sci (2002) 1.08
Molecular mechanisms of the synergistic induction of ornithine decarboxylase by asparagine and glucagon in primary cultured hepatocytes. J Biol Chem (1987) 1.07
Pathogenesis of abortion of bovine brucellosis. Comp Immunol Microbiol Infect Dis (1993) 1.07
Attenuation of a Brucella abortus mutant lacking a major 25 kDa outer membrane protein in cattle. Am J Vet Res (2001) 1.06
Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol (2009) 1.06
Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol (2000) 1.06
Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect Immun (2001) 1.06
Elimination of genital vibriosis in female cattle by systemic immunization with killed cells or cell-free extracts of Campylobacter fetus. J Infect Dis (1978) 1.02
Purification and characterization of heat-stable enterotoxin from bovine enterotoxigenic Escherichia coli. Infect Immun (1983) 1.00
Brugia pahangi: effects of duration of infection and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity, and immune responses in jirds (Meriones unguiculatus). Exp Parasitol (1990) 1.00
Brucella vaccines in wildlife. Vet Microbiol (2002) 1.00
A Brucella melitensis high temperature requirement A (htrA) deletion mutant demonstrates a stress response defective phenotype in vitro and transient attenuation in the BALB/c mouse model. Microb Pathog (1995) 1.00
In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines. Pept Res (1992) 1.00
Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis. J Med Microbiol (1991) 0.99
Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308. Vet Pathol (1993) 0.99
Purification and properties of agmatine ureohydrolyase, a putrescine biosynthetic enzyme in Escherichia coli. J Bacteriol (1986) 0.99
Locations of the speA, speB, speC, and metK genes on the physical map of Escherichia coli. J Bacteriol (1990) 0.97
Cytochromes P450 in crustacea. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1998) 0.97
Localization of brucella antigens that elicit a humoral immune response in Brucella abortus-infected cells. Infect Immun (1981) 0.95
The granulomatous inflammatory response in jirds, Meriones unguiculatus, to Brugia pahangi: an ultrastructural and histochemical comparison of the reaction in the lymphatics and peritoneal cavity. J Parasitol (1987) 0.95
Effect of the antimicrobial peptide, D-hecate, on trichomonads. J Parasitol (2000) 0.95